Accessibility and Affordability Boost the Bone Scan Market Worldwide
North America dominates the Bone Scan Market, driven by advanced healthcare systems, high prevalence of bone disorders, and widespread insurance coverage.
The market was worth USD 825 million in 2023 globally, and North America accounts for a significant share. With increasing use of nuclear imaging in cancer and orthopedic diagnostics, the region will remain a leader through 2032.
Ongoing R&D investments and rapid technology adoption also position the Bone Scan Market in North America for sustained leadership.